Atlantic Health Partners program adds new adult hepatitis B vaccine
ISMA’s vaccine buying group partner, Atlantic Health Partners, has added Dynavax’s Heplisav-B vaccine to its comprehensive portfolio of immunizations. Heplisav-B is the only two-dose series adult hepatitis B vaccine approved for patients 18 and older, and it provides higher levels of immunity than other adult hepatitis B vaccines.

Additional benefits of Atlantic’s program include:
  • Favorable pricing for Merck, Sanofi and Pfizer (Trumenba) vaccines.
  • Excellent service and support for all immunization needs.
  • Easy “one-stop shop” ordering for most vaccines.
Join the many other ISMA members already benefiting from Atlantic’s program. Contact Cindy Berenson or Jeff Winokur with Atlantic Health Partners to see how they can help lower your vaccine costs and improve your immunization efforts. Their contact information is (800) 741-2044 or info@atlantichealthpartners.com.

For more information on Atlantic Health Partners, visit www.atlantichealthpartners.com.